Ameriprise’s Lam Research LRCX Stock Holding History

Ameriprise’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-65,000	Closed	-$516K	–	3822
2015 Q4	$516K	Buy	+65,000	New	+$489K	﹤0.01%	3253

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's LRCX Position: Q1 2026 in Review

Ameriprise reduced its Lam Research (LRCX) stake by 11% in Q1 2026, selling an estimated $551M and leaving 20,788,130 shares worth $4.44B. The position accounts for 1.03% of the portfolio, ranked #9.

Ameriprise first reported a position in LRCX in Q2 2013 and has held it in 52 quarters since. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Ameriprise held 20,788,130 shares of Lam Research worth $4.44B as of Q1 2026.
Ameriprise sold 2,462,212 Lam Research shares in Q1 2026, an estimated $551M.
Lam Research made up 1.03% of Ameriprise's portfolio in Q1 2026, its #9 holding.
Ameriprise first reported a position in Lam Research in Q2 2013 and has held it in 52 quarters since.
2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.